Neuroval (Clotiazepam)

Quick links

Choose a section

Quick links to important sections

Advertisements

Neuroval (Clotiazepam)

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Neuroval (Clotiazepam)

Property Description
Active ingredient Clotiazepam (INN)
Form Tablet (Oral formulation)
Pharmacological class Anxiolytic; Thienodiazepine derivative
General purpose Relief from anxiety and tension
Origin Synthetic compound

What Type of Medicine is Neuroval (Clotiazepam)?

Neuroval is a prescription-only medication whose active ingredient is Clotiazepam, chemically classified as a thienodiazepine derivative. This synthetic compound is recognized as an anxiolytic and a Central Nervous System (CNS) depressant, intended to reduce elevated neural activity. Clotiazepam shares its core action and is categorized within the Anatomical Therapeutic Chemical (ATC) system within the N05BA group for benzodiazepine derivatives. Unlike many older benzodiazepines, Clotiazepam is characterized by a relatively short elimination half-life (approximately four hours), which influences the duration of its clinical effects.

What is the General Purpose of Clotiazepam?

The general purpose of Clotiazepam is to provide symptomatic relief from pronounced psychological and physical tension, a function for which it is clinically recognized across multiple international regions. It achieves this by acting as a positive allosteric modulator of the GABAA receptor, a mechanism that strongly enhances the inhibitory effects of the neurotransmitter GABA. This amplification of central inhibition leads to its overall benefit: effective management of anxiety, psychological distress, and associated symptoms such as restlessness, muscle tension, or trouble with sleep initiation. The medication is utilized for the rapid reduction of peak anxiety levels in patients.

In What Form is Clotiazepam Supplied?

Clotiazepam is typically supplied as an oral formulation, manufactured in the physical form of a tablet, intended for systemic action after ingestion. The medication is a single-agent product, containing Clotiazepam as the sole active compound, along with necessary solid oral excipients used in tablet creation. In some regions, forms such as dispersible tablets may be available, differentiating its delivery from standard oral tablets.

Advertisements

What side effects are possible with Neuroval (Clotiazepam)?

Possible Side Effects and Safety Information

The following safety information for Clotiazepam is based strictly on documentation from government regulatory agencies, detailing officially documented adverse reactions and safety constraints.

Officially Documented Adverse Reactions

Adverse effects are categorized by System-Organ Class (SOC) and frequency based on official reporting data. The most frequently documented reactions relate to the central nervous system (CNS).

System-Organ Class Common Adverse Effects Uncommon Adverse Effects
Nervous System Drowsiness, Dizziness, Light-headedness Headache, Insomnia (paradoxical), Ataxia
Gastrointestinal Dry mouth Nausea, Vomiting, Constipation
Musculoskeletal — Muscle weakness

Serious Adverse Reactions and Safety Warnings

Official regulatory labeling highlights several clinically significant safety concerns:

  • Drug Dependence and Withdrawal: Both physical and psychological dependence are explicitly warned risks associated with Clotiazepam, particularly following long-term use or administration at high doses. Discontinuation must be managed due to the risk of severe withdrawal symptoms.
  • Paradoxical Reactions: Psychiatric effects such as excitation and confusion have been documented as adverse reactions.

Safety Considerations and Restrictions

  • Contraindications: Clotiazepam is restricted for use in individuals with conditions such as severe myasthenia gravis, acute narrow-angle glaucoma, and severe respiratory insufficiency.
  • Older Adults: Geriatric patients require caution due to increased sensitivity to CNS effects (e.g., ataxia, dizziness), which increases the documented risk of falls.
  • Drug Interactions: Concurrent use with alcohol or other CNS depressants is warned against, as it can lead to enhanced sedative effects and potentially severe respiratory compromise.
Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Neuroval (Clotiazepam) primarily involves escalating Central Nervous System (CNS) depression. Documented manifestations start with less severe signs like somnolence, confusion, impaired balance (ataxia), and slurred speech (dysarthria). In severe cases, this depression can progress to profound lethargy and coma.

The most critical, life-threatening outcomes are respiratory depression and severe hypotension. The risk of these severe consequences, including cardiac arrest and death, is significantly increased when the medication is taken with alcohol, opioids, or other CNS depressants.

For any sign of severe CNS impairment, particularly difficulty breathing or unresponsiveness, immediate medical attention must be sought. Official regulatory documents state that treatment is centered on symptomatic and supportive care, emphasizing airway maintenance and continuous monitoring of vital signs. While Flumazenil, a specific antagonist, is documented, its use carries a regulatory warning regarding the potential for inducing seizures and is therefore often limited in clinical practice.

Advertisements

Therapeutic Uses of Neuroval (Clotiazepam)

What Neuroval (Clotiazepam) Treats: Main Uses and Benefits

Neuroval (Clotiazepam) is considered relevant for easing various symptoms that create noticeable physiological strain. It is commonly used across conditions presenting with symptoms that interfere with daily functioning, including anxiety states, sleep disruption associated with stress, and psychosomatic complaints.

Supportive relief during acute or unstable symptom patterns is an important benefit of this medication. Neuroval assists with maintaining functional stability by managing core psychological distress, including worry and restlessness, as well as symptoms related to heightened physiological activity, such as tension and agitation.

“It supports patients during difficult episodes by easing distress and contributes to easing the overall symptom load.”

Quick Fact: Supportive Relief for Nervous Tension and Insomnia

Neuroval is commonly used when short-term symptomatic assistance is needed for symptoms related to physical discomfort and for sleep disruption associated with anxiety.

Regulatory References

  1. Japanese Drug Information Sheet
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Neuroval (Clotiazepam)?

Eligibility Scope

Classification Status According to Regulatory Documents
Populations for whom use is allowed Adults who do not meet any criteria for restriction or prohibition.
Populations for whom use is not recommended Children and adolescents (use is not established). Nursing mothers (an alternate drug is preferred).
Populations for whom use is contraindicated Severe Hepatic Insufficiency, Severe Respiratory Insufficiency, Myasthenia Gravis, Hypersensitivity to Clotiazepam or the benzodiazepine class, Sleep Apnea Syndrome, and Acute Narrow-Angle Glaucoma.

Eligibility-Related Restrictions

Restriction Category Official Regulatory Statement
Age-related eligibility rules Older adults require special caution due to a mandated warning on the risk of falls and increased sensitivity to CNS depressant action.
Condition-specific eligibility rules Mild to moderate hepatic impairment requires caution; severe impairment is contraindicated. Use requires caution in patients with renal impairment.
Physiological status Use is restricted and generally avoided during pregnancy. Use is not recommended during lactation.
Comorbidity constraints Use requires extreme caution in patients with a history of alcohol or drug dependence.

Connection to the overall eligibility profile

Official regulatory documents establish non-eligibility by formally prohibiting use in populations with pre-existing conditions, such as severe organ failure or specific neuromuscular diseases. Eligibility for all other groups is conditional, imposing caution for vulnerable populations like the elderly and those with hepatic impairment, and restricting use in children and during lactation, as mandated by government standards.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Neuroval (Clotiazepam) by classifying both pharmacodynamic and pharmacokinetic risks. Factual statements are derived from official prescribing information, including the FDA benzodiazepine class warnings and national drug information sheets.

Interaction Scope

Property Documented Regulatory Statement
Medicinal product categories with documented interactions CNS Depressants (e.g., Anxiolytics, Hypnotics); Opioid Products; CYP Enzyme Inhibitors; CYP Enzyme Inducers.
Mechanistic basis of interactions Pharmacodynamic Interaction (Additive CNS depression); Pharmacokinetic Interaction (Modification of metabolism via CYP2C19 and CYP3A4).
Interaction-related restrictions Formal prohibition of co-administration with Opioid medicines due to the risk of profound sedation and respiratory depression.

Resulting Interaction Structure

Co-administration with Opioid products (such as codeine or morphine) is subject to formal restrictions due to the documented risk of severe, additive Central Nervous System (CNS) depression. Similarly, concurrent use with other CNS Depressant medications may lead to enhanced clinical effects and severe sedation. The intake of Alcohol is also documented to enhance the effect of Clotiazepam. Substances that inhibit hepatic enzymes CYP2C19 and CYP3A4 may decrease metabolism, resulting in increased systemic exposure. Conversely, enzyme inducers may increase metabolism, leading to reduced systemic exposure of Clotiazepam.

Advertisements

Mechanism of Action

Clotiazepam operates as a Positive Allosteric Modulator (PAM), targeting the mathbfGABAmathbfA receptor complex, a principal site for inhibitory action within the Central Nervous System (CNS). This molecular engagement enhances the effect of the endogenous neurotransmitter gamma-aminobutyric acid (GABA) by increasing the frequency of the receptor's channel openings.

This augmented GABA activity drives a greater influx of negatively charged chloride ions (Cl^-) into the postsynaptic neuron. The subsequent accumulation of negative charge causes the neuron to hyperpolarize (become less excitable). This cellular cascade immediately reduces the firing potential of nerve cells, resulting in a widespread reduction in neuronal excitability across the CNS. The overall physiological modulation is the direct consequence of this sustained central inhibition. The drug's molecular mechanism is fundamentally dependent on the natural release of endogenous GABA; it requires the presence of the neurotransmitter to modulate the receptor.

Advertisements

Dosage and Administration Information

How to Use Neuroval (Clotiazepam) — Administration Guidelines

Clotiazepam administration is governed by instructions detailing the route, dosing structure, and frequency, based on the context of use. As a single-agent product, it is most commonly supplied in tablet form.


Administration Scope

Parameter Instruction
Route of administration Oral administration for the available tablet form.
Dosing Forms Tablets are available in strengths of 5 mg and 10 mg of the active ingredient.
Standard Daily Dosing Daily doses typically range from 5 mg to 15 mg of the active ingredient, determined by the specific need.
Frequency Pattern For routine use, the total daily dose is commonly divided and administered three times a day.
Preanesthetic Schedule For preanesthetic use, a single dose of 10 mg to 15 mg is taken either before bedtime or immediately before surgery.

Procedural and Population Instructions

General instructions provide high-level guidance regarding administration timing and dosage adjustments:

  • Dose Adjustment: The total amount of Clotiazepam administered may be determined and adjusted according to the patient's age and symptoms.
  • Missed Dose Management: If a scheduled dose is missed, it should be taken as soon as it is remembered. However, the missed dose must be skipped if the next scheduled dose is near. Patients are instructed never to take two doses at one time to compensate for a missed dose.

These instructions define the standardized approach to administering Clotiazepam, structuring the medication's use around its oral route, its typical divided daily frequency, and specific dosage amounts for different administration contexts.

Advertisements

Recent Clinical Evidence

Neuroval (Clotiazepam): Recent Clinical Evidence

Overview of Clinical Trials

Research has examined the activity of the compound, a thienodiazepine derivative, on the symptoms of anxiety and tension, as well as psychosomatic disorders. Clinical trials have involved adult participants, often focusing on the compound's use for the short-term management of anxiety. The primary study endpoint commonly evaluated was the symptomatic change measured using standardized rating scales, such as the Hamilton Scale, over periods typically lasting a few weeks.

Studies have assessed Clotiazepam both as a stand-alone therapy (monotherapy) and in conjunction with existing treatments. Findings from these trials reported statistically significant reductions in total anxiety scores in many participants, including both somatic and psychological symptoms of anxiety. Research compared the drug's primary endpoints to those of other compounds in its class; overall findings reported from these comparisons were mixed regarding comparative efficacy.

Safety and Pharmacokinetic Findings

As with other drugs in this class, Clotiazepam possesses anxiolytic, sedative, anticonvulsant, and muscle relaxant properties. The compound has a relatively short elimination half-life, ranging from approximately 6.5 to 18 hours, which may result in less accumulation after repeated dosing compared to longer-acting agents. It is metabolized in the liver, and researchers have noted that clearance may be reduced in individuals with liver impairment, as well as in elderly men.

Commonly reported adverse events in clinical studies include drowsiness and asthenia (physical weakness or lack of energy). Phase 4 studies have also monitored for more serious, rare adverse effects, such as reversible liver dysfunction. Due to the known risks associated with the entire class of benzodiazepine-like drugs, Clotiazepam carries risks of tolerance, physical dependence, and withdrawal symptoms, even when used as prescribed.

Key Studies & References Clotiazepam International Programme on Chemical Safety Poisons Information Monograph 922

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Neuroval (Clotiazepam) (FAQ)


Q: How quickly do the effects of Neuroval typically start to be noticed?

A: Official pharmacological data indicates that the active compound, Clotiazepam, is rapidly absorbed after it is taken orally. Rapid absorption is a characteristic of the compound, and official information describes some formulations (e.g., liquid drops) as providing a more marked initial effect.


Q: What is the average duration of action for Neuroval?

A: Official pharmacokinetic information reports the elimination half-life of Neuroval and its metabolites ranges from approximately 6.5 to 18 hours. This characteristic half-life influences the drug's overall duration of clinical effect and is generally associated with a shorter duration compared to compounds with longer half-lives.


Q: Can Neuroval be taken with over-the-counter pain relievers like ibuprofen?

A: Regulatory documents advise caution when using Neuroval with any other medication that causes central nervous system (CNS) depression, as this could lead to increased effects like sedation or sleepiness. Regulatory sources advise consultation with a healthcare professional regarding potential interactions with all concurrent medications, including over-the-counter pain relievers.


Q: Are there any specific foods or drinks that should be avoided when using Neuroval?

A: Official warnings state that the consumption of alcohol with this medicine is to be avoided. Alcohol consumption can intensify the drug’s depressive effects on the central nervous system, increasing the risks of drowsiness and decreased attention.


Q: Does Neuroval interact with common antidepressant medications (SSRIs)?

A: Official regulatory warnings state that Neuroval should be used with caution when taken concurrently with other CNS Depressant medications. Some types of antidepressant medications, such as SSRIs, may be included in this broad category, potentially leading to enhanced sedative effects.


Q: Is it safe to drive or operate machinery while taking Neuroval?

A: Official drug precautions explicitly state that this medication may cause side effects such as drowsiness, decreased attention, concentration, and slowed reflex movement. Regulatory documents state that patients should not operate dangerous machinery or drive while taking this medicine due to the risk of reduced alertness.


Q: Is Neuroval safe for use in older adults?

A: Official regulatory documents indicate that older adults require special caution when using this medication. This is due to their increased sensitivity to the drug's CNS depressant effects, such as dizziness and problems with coordination (ataxia), which may lead to an increased risk of falls.


Q: Does Neuroval have a black box warning in the United States?

A: While Neuroval (Clotiazepam) may not be approved in the United States, the FDA has issued a Boxed Warning for the entire benzodiazepine drug class. This warning emphasizes the serious risks of addiction, abuse, and withdrawal, especially when used with opioid medicines.


Q: Does Neuroval interfere with hormonal birth control?

A: Official documents mention that Neuroval's metabolism involves specific CYP liver enzymes. While a specific restriction for hormonal birth control is not universally listed, official regulatory information addresses potential interactions based on metabolism via CYP liver enzymes.


Q: Can Neuroval be split or crushed, based on regulatory guidance?

A: Official administration instructions specify the use of the oral tablet form. Guidance on physically modifying (splitting or crushing) standard oral tablets is highly specific to the product formulation and is typically found only on the product label or within the prescribing information.


Q: What population groups have the most published research on Neuroval?

A: Clinical trials and research on the drug have primarily involved adult participants and focused on the short-term management of anxiety symptoms. Separate pharmacological observations, such as drug clearance, have also been specifically noted in elderly men.


Q: Is Neuroval intended for daily use or as needed?

A: Official regulatory documents define a standard daily dosing regimen where the total dose is commonly divided and administered three times a day for routine treatment. Official regulatory documents define a standard daily dosing regimen where the total dose is commonly divided and administered three times a day for routine treatment.


Q: Is Neuroval the same type of medication as Valium (Diazepam)?

A: Neuroval (Clotiazepam) is chemically classified as a thienodiazepine derivative. While it shares a core mechanism and is categorized by the WHO-ATC system with benzodiazepine derivatives like Valium (Diazepam), it is structurally distinct from traditional benzodiazepines.


Q: What is the main difference between Neuroval and other anxiety medicines?

A: Neuroval is specifically a thienodiazepine derivative and is characterized by a relatively short elimination half-life compared to some other medicines in its class. This short half-life suggests that the drug may have less tendency to accumulate in the body after repeated dosing.


Q: Are there common side effects that usually go away after a few days?

A: Official information for this drug class notes that the most frequently occurring side effects, such as drowsiness and problems with coordination, may diminish with time in some individuals as their body adjusts to the medication.


Q: Can Neuroval be used during pregnancy, according to regulatory information?

A: Official regulatory documents state that use of Neuroval is restricted and generally avoided during pregnancy. This restriction is due to documented potential risks to the developing fetus.


Q: How does Neuroval compare to Xanax (Alprazolam) in terms of general classification?

A: Both Neuroval (Clotiazepam) and Xanax (Alprazolam) are grouped by the World Health Organization's Anatomical Therapeutic Chemical (ATC) system within the N05BA group. This common classification indicates that both are benzodiazepine derivatives intended for similar principal uses as anxiolytics.


Q: Is Neuroval a type of tranquilizer?

A: Neuroval (Clotiazepam) is officially classified as an anxiolytic—a medication used to reduce anxiety—and a Central Nervous System (CNS) depressant. The term 'minor tranquilizer' is an older, non-clinical term that was historically used to refer to this category of anxiety-reducing medication.


Q: Does taking Neuroval affect blood pressure?

A: While the most common side effects relate to the central nervous system, official regulatory side effect listings for this drug class have included rare or infrequent cardiovascular effects. These may include instances of postural hypotension, which is a drop in blood pressure when standing up.


Q: Can Neuroval cause changes in appetite or weight?

A: Official regulatory side effect listings for this drug class have included infrequent reports of changes in appetite, such as both a loss of appetite and an increased appetite. Both weight loss and weight gain have also been noted in clinical reports as infrequent possible effects.


Q: What happens if Neuroval is taken for a longer period than intended?

A: Official safety warnings explicitly cite the risks of tolerance, where the effect lessens over time, and the development of physical and psychological dependence. These risks are specifically linked to administration over long-term use or at high doses.


Q: Do any official sources mention Neuroval causing increased anxiety or agitation?

A: Yes, official regulatory labeling highlights the risk of Paradoxical Reactions, which are documented side effects. These can include psychiatric effects such as excitation and confusion, which may present as increased agitation.


Q: Can Neuroval be used to treat panic attacks?

A: Neuroval’s approved purpose is the symptomatic relief of pronounced anxiety and tension. While similar drugs in this class are specifically indicated for panic disorder, official labeling for Neuroval focuses on the management of general anxiety and associated symptoms.


Q: Is Neuroval associated with any specific risks in patients with a history of substance use?

A: Yes, official regulatory documents mandate extreme caution for patients who have a history of alcohol or drug dependence. This is due to the documented risks of dependence and potential abuse associated with this class of medication.


Q: Are there specific instructions for what to do in case of an overdose with Neuroval?

A: General guidance for this drug class notes that a suspected overdose requires immediate emergency medical attention. Symptoms of an overdose may include extreme drowsiness, confusion, loss of coordination, or coma.


Q: Are there generic versions of Neuroval (Clotiazepam) available?

A: Clotiazepam is the active ingredient name. Global pharmaceutical data confirms that the active ingredient is manufactured and supplied worldwide for use in creating generic API (Active Pharmaceutical Ingredient) products.


Q: Does Neuroval interact with caffeine?

A: Available drug interaction data indicates that the therapeutic efficacy (or effectiveness) of Clotiazepam can potentially be decreased when used in combination with Caffeine.


Q: Why do some people refer to Neuroval as a 'minor tranquilizer'?

A: Neuroval (Clotiazepam) is officially classified as an anxiolytic and a Central Nervous System (CNS) depressant. The term 'minor tranquilizer' is an older, non-clinical term that was historically used to refer to this category of anxiety-reducing medication.


Q: Are there official recommendations for monitoring while on Neuroval?

A: For long-term therapy with this drug class, official guidance generally advises that periodic blood counts and liver function tests may be advisable. Such monitoring is intended to check for any health status changes over the course of treatment.


Q: Is Neuroval a Schedule IV controlled substance?

A: In many jurisdictions where it is regulated, Clotiazepam is classified as a controlled substance, often listed under Schedule IV. This designation indicates that the drug has a recognized medical use but also a low potential for abuse relative to Schedule III substances.

Advertisements

How should Neuroval (Clotiazepam) be stored and disposed of?

Neuroval (clotiazepam) must be stored and handled according to specific regulatory requirements to maintain the product’s quality and safety.

Storage Requirements

Condition Requirement (Official Labeling)
Container & Protection Store in a light-resistant and tight container [1.3]. Must be protected from light, moisture, and excessive heat [1.2, 4.5].
Temperature Should be protected from freezing and excessive heat (above 40 C), based on stability standards [4.5].
Child Safety Mandatory requirement to keep out of the reach of children [1.2]. The product should be stored in a secure manner [1.5].

Disposal Instructions

Any remainder of the medicine must be discarded and not stored [1.2]. Disposal of both the contents and container must be carried out in accordance with local, regional, national, and international regulations [1.5]. This process includes taking precautions to avoid environmental release into sewers or surface water [1.5]. Unused portions should be handled as pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Neuroval (Clotiazepam) found in:

A-Z Index: